SG11201508336TA - Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere - Google Patents

Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere

Info

Publication number
SG11201508336TA
SG11201508336TA SG11201508336TA SG11201508336TA SG11201508336TA SG 11201508336T A SG11201508336T A SG 11201508336TA SG 11201508336T A SG11201508336T A SG 11201508336TA SG 11201508336T A SG11201508336T A SG 11201508336TA SG 11201508336T A SG11201508336T A SG 11201508336TA
Authority
SG
Singapore
Prior art keywords
ribonucleoside analogues
mercaptopurine ribonucleoside
altering
mediated telomere
telomerase mediated
Prior art date
Application number
SG11201508336TA
Other languages
English (en)
Inventor
Jerry W Shay
Sergei M Gryaznov
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of SG11201508336TA publication Critical patent/SG11201508336TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201508336TA 2013-04-08 2014-04-08 Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere SG11201508336TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361809575P 2013-04-08 2013-04-08
PCT/US2014/033330 WO2014168947A2 (en) 2013-04-08 2014-04-08 Telomerase mediated telomere altering compounds

Publications (1)

Publication Number Publication Date
SG11201508336TA true SG11201508336TA (en) 2015-11-27

Family

ID=50819958

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201508336TA SG11201508336TA (en) 2013-04-08 2014-04-08 Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere
SG10202002556QA SG10202002556QA (en) 2013-04-08 2014-04-08 Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202002556QA SG10202002556QA (en) 2013-04-08 2014-04-08 Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere

Country Status (17)

Country Link
US (1) US10463685B2 (enrdf_load_stackoverflow)
EP (2) EP2983675A2 (enrdf_load_stackoverflow)
JP (1) JP6525956B2 (enrdf_load_stackoverflow)
KR (1) KR20150143587A (enrdf_load_stackoverflow)
CN (2) CN105338987A (enrdf_load_stackoverflow)
AU (1) AU2014251093B2 (enrdf_load_stackoverflow)
BR (1) BR112015025206A2 (enrdf_load_stackoverflow)
CA (1) CA2907924C (enrdf_load_stackoverflow)
ES (1) ES3038057T3 (enrdf_load_stackoverflow)
HK (1) HK1219418A1 (enrdf_load_stackoverflow)
HU (1) HUE072426T2 (enrdf_load_stackoverflow)
MX (1) MX387008B (enrdf_load_stackoverflow)
NZ (1) NZ713498A (enrdf_load_stackoverflow)
PL (1) PL3682888T3 (enrdf_load_stackoverflow)
RU (1) RU2713555C2 (enrdf_load_stackoverflow)
SG (2) SG11201508336TA (enrdf_load_stackoverflow)
WO (1) WO2014168947A2 (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017165675A1 (en) * 2016-03-24 2017-09-28 The Board Of Regents Of The University Of Texas System Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds
CA3025522A1 (en) * 2016-05-27 2017-11-30 The Board Of Regents Of The University Of Texas System 6-thio-2'-deoxyguanosine (6-thio-dg) results in telomerase dependent telomere dysfunction and cell death in various models of therapy-resistant cancer cells
US20210023107A1 (en) * 2018-03-22 2021-01-28 The Board Of Regents Of The University Of Texas System USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS
AU2019208197B2 (en) 2018-07-31 2025-05-29 Howmedica Osteonics Corp. Fixation devices and prostheses for soft tissue connection to the same
WO2020081690A1 (en) 2018-10-17 2020-04-23 Xibin Liao 6-mercaptopurine nucleoside analogues
USD1046142S1 (en) 2019-07-24 2024-10-08 Howmedica Osteonics Corp. Proximal tibial prosthesis
CN112898292A (zh) 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途
MX2022011331A (es) 2020-03-13 2022-10-27 Univ Texas Tratamiento secuencial de canceres utilizando 6-tio-dg, inhibidores de puntos de control y radioterapia.
CN121002041A (zh) * 2023-03-14 2025-11-21 浙江华海药业股份有限公司 一类靶向端粒酶的核苷类似物及其应用
WO2024188308A1 (zh) * 2023-03-14 2024-09-19 上海华汇拓医药科技有限公司 一类核苷类似物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209226A (en) * 1981-06-18 1982-12-22 Yamasa Shoyu Co Ltd Antitumor activity intensifier
EP0570519B1 (en) * 1991-02-08 1999-05-06 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
WO2006114065A2 (en) 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry A Cademy Of Sciences Of The Czech Republic Use of compounds to inhibit neoplasia
CN101220071B (zh) * 2008-01-17 2011-04-06 南京长澳医药科技有限公司 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物
US20100323979A1 (en) * 2009-06-16 2010-12-23 Weis-Amon Angelika B Methods and compositions for inhibiting proliferation of aneuploid cells

Also Published As

Publication number Publication date
WO2014168947A9 (en) 2014-12-31
RU2015147555A (ru) 2017-05-15
WO2014168947A3 (en) 2015-02-19
ES3038057T3 (en) 2025-10-09
JP2016516773A (ja) 2016-06-09
NZ732228A (en) 2020-11-27
HUE072426T2 (hu) 2025-11-28
MX387008B (es) 2025-03-19
EP3682888A1 (en) 2020-07-22
RU2713555C2 (ru) 2020-02-05
KR20150143587A (ko) 2015-12-23
HK1219418A1 (zh) 2017-04-07
CN105338987A (zh) 2016-02-17
JP6525956B2 (ja) 2019-06-05
SG10202002556QA (en) 2020-04-29
CN110339203A (zh) 2019-10-18
WO2014168947A2 (en) 2014-10-16
AU2014251093A1 (en) 2015-10-15
PL3682888T3 (pl) 2025-09-22
US20140303239A1 (en) 2014-10-09
AU2014251093B2 (en) 2017-06-15
MX2015014159A (es) 2016-06-21
CA2907924A1 (en) 2014-10-16
NZ713498A (en) 2017-07-28
US10463685B2 (en) 2019-11-05
EP3682888B1 (en) 2025-06-11
EP2983675A2 (en) 2016-02-17
BR112015025206A2 (pt) 2017-07-18
CA2907924C (en) 2022-10-25

Similar Documents

Publication Publication Date Title
SG11201508336TA (en) Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere
AU359765S (en) Bus
GB2541833B (en) Improvements to implant surfaces
SG11201605011WA (en) Icebreaking vessel
GB201309236D0 (en) Delay adjustment
EP2986719A4 (en) FUSION POLYMERASES
ZA201702401B (en) Composition with reduced immunogenicity
IL239680A0 (en) Preparations and methods for polynucleotide transfection
GB2532042B (en) Pure delay estimation
SG11201602845UA (en) Pyrometer background elimination
IL248627A0 (en) Amorphous form of apramilst
GB201715452D0 (en) Coconut tap
PL2868251T3 (pl) Zmywarka do naczyń z przesunięciem startu
GB2538045B (en) Improvements to letter-plates
HUE053526T2 (hu) Telomeráz-reverz-transzkriptáz alapú terápiák
PT3176022T (pt) Autocarro
IL240171A0 (en) A crystalline form of linaclotide
TWM490369U (en) Tapping structure
GB201400008D0 (en) Hoffman artgrip
GB201521028D0 (en) Improvements to Li-fi
AU2015316V (en) SUPA2221 Argyranthemum frutescens
GB201403763D0 (en) CWM with CSR
GB201503659D0 (en) CWM with CSR
AU362337S (en) Coconut tap
GB201509104D0 (en) Batterys